The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.
Dublin, April 30, 2026 (GLOBE NEWSWIRE)-- The "Pharmaceutical API Manufacturing Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pharmaceutical API manufacturing market has ...
SHANGHAI, SHANGHAI, CHINA, June 5, 2026 / EINPresswire.com / — WuXi AppTec is accelerating a broad global manufacturing expansion across the United States, Europe, and Asia as customer demand for drug ...
The big unknown is whether CDMO capacity built for branded drugs gets diverted to generics, and whether SPPS can scale fast ...
MISSISSAUGA, Ontario, April 16, 2026--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the ...
Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...
Goldman Sachs reports the future of semaglutide genericisation and GLP-1 pricing hinges on peptide API manufacturing capacity ...
What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port ...
Amazon Filters is a leading manufacturer of bespoke filter housings and high-performance filter media used in the manufacture of Active Pharmaceutical Ingredients (API's) - vital building blocks for ...
Japan’s Pharmaceutical and Medical Devices Agency (PMDA) announced Thursday that it will join with the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) and other regulators ...
BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from ...